Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Sacubitril/Valsartan in Acute Myocardial Infarction
ChiCTR2100042337Phase 4Recruiting
- Sponsor
- The Seventh People's Hospital of Zhengzhou
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sacubitril + valsartan in myocardial infarction (MI) and heart failure (HF) (2 arms), sponsored by The Seventh People's Hospital of Zhengzhou. Primary endpoints: Cardiovascular mortality, Incidence of heart failure and 2 more. Started Oct 2020; status: recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
myocardial infarction (MI)heart failure (HF)
Beyond the preview
Go deeper on ChiCTR2100042337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042337.